These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2537663)

  • 1. 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.
    Hamik A; Peroutka SJ
    Biol Psychiatry; 1989 Mar; 25(5):569-75. PubMed ID: 2537663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites.
    Hamik A; Oksenberg D; Fischette C; Peroutka SJ
    Biol Psychiatry; 1990 Jul; 28(2):99-109. PubMed ID: 1974152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
    Baumann MH; Mash DC; Staley JK
    Neuroreport; 1995 Nov; 6(16):2150-2. PubMed ID: 8595191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
    Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors.
    Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE
    J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimigraine drug interactions with serotonin receptor subtypes in human brain.
    Peroutka SJ
    Ann Neurol; 1988 May; 23(5):500-4. PubMed ID: 2898916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]rauwolscine behaves as an agonist for the 5-HT1A receptors in human frontal cortex membranes.
    De Vos H; Czerwiec E; De Backer JP; De Potter W; Vauquelin G
    Eur J Pharmacol; 1991 May; 207(1):1-8. PubMed ID: 1680719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
    Howe JR; Yaksh TL
    Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 5-hydroxytryptamine1D binding sites in human brain membranes.
    Peroutka SJ; Switzer JA; Hamik A
    Synapse; 1989; 3(1):61-6. PubMed ID: 2521959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.
    Borbe HO; Zierenberg O
    Pharmacopsychiatry; 1985 Sep; 18(5):314-9. PubMed ID: 2996040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
    Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.
    Ulrichsen J; Partilla JS; Dax EM
    Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD; Fields JZ; Yamamura HI
    Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.
    Waldmeier PC; Wicki P; Fröstl W; Bittiger H; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):670-8. PubMed ID: 9053740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trifluoromethylphenyl piperazine derivative with high affinity for 5-hydroxytryptamine-1A sites in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1985 Mar; 44(3):875-80. PubMed ID: 3838340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding properties of amperozide.
    Svartengren J; Simonsson P
    Pharmacol Toxicol; 1990; 66 Suppl 1():8-11. PubMed ID: 2154737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety.
    Smith TM; Suckow RF
    Neuropharmacology; 1985 Nov; 24(11):1067-71. PubMed ID: 4080105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.